openPR Logo
Press release

The US Polycystic Ovarian Syndrome Treatment Market to prove to be the digitized mouthpiece at a CAGR of 3.9%

05-30-2022 06:38 AM CET | Health & Medicine

Press release from: Persistence Market Research

The US Polycystic Ovarian Syndrome Treatment Market to prove

The US Polycystic Ovarian Syndrome Treatment Market is expected to witness a staggering CAGR going forward. The gamut of care is being driven by the usage of sensors, digital technologies, and wearables, thereby allowing the healthcare personnel to delve deep into the patients' live - be it pre-operative, post-operative, or the period in between. Consumer tech companies are into making caregivers visible outside of the clinical environment a reality.

Prevalence of endocrine diseases in the US is on a rise as the country's urban residents continue to bear the brunt of their sedentary lifestyles. Rising incidence of endometriosis, unexplained infertility and polycystic ovarian syndrome (PCOS) continues to alarm public health authorities across the US. Measures undertaken by non-profit organizations and US health regulatory bodies are promoting the awareness of PCOS treatments. Also, therapies for diseases associated with PCOS are being developed to bear out the unmet clinical needs of people suffering from such complications.

Get Going With Sample Of Us Polycystic Ovarian Syndrome Treatment Market Report! https://www.persistencemarketresearch.com/samples/14317

Despite this, the demand for PCOS treatment continues to incur a sluggish growth across the US. Persistence Market Research's recent publication estimates that the US$ 230 Mn PCOS treatment market in the US will exhibit a moderate value CAGR of 3.9% to reach US$ 313.2 Mn by the end of 2024.

Company Profiles:

Sanofi
Novartis AG
Teva Pharmaceutical Industries Limited
Merck KGaA
AstraZeneca

How About Re-Inventing The Methodical Wheel In The Us Polycystic Ovarian Syndrome Treatment Market? Switch Over To The "Methodology" Tab! https://www.persistencemarketresearch.com/methodology/14317

The foremost growth inhibitor for polycystic syndrome treatment market in the US is pending approval of drugs at the FDA. The US FDA continues to prolong the approval for drugs on polycystic syndrome treatment. And, this has severely lowered the production of effective medicines, thereby impacting the adoption of PCOS treatment. Presently, no drugs have been approved by the FDA for direct treatment of PCOS. Physicians are thus providing drug prescriptions through off-label indications, which is incidentally diverting patients to generic drugs.

Keeping A Tab On Key Players In The Us Polycystic Ovarian Syndrome Treatment Market? Go To "Purchase Now" To Decipher The Competitive Analysis In Our Us Polycystic Ovarian Syndrome Treatment Market Report! https://www.persistencemarketresearch.com/checkout/14317

Titled as "PCOS Market: US Industry Analysis and Forecast, 2016-2024," the report projects that in 2016, more than US$ 66 Mn worth of oral contraceptive drugs were consumed in the US PCOS market. Through 2024, oral contraceptives will be exhibiting a steady revenue growth at 5.3% CAGR, and will account for nearly one-third share of market value. Besides, the demand for insulin sensitizing agents is expected to close in on number of oral contraceptives consumed in the US PCOS treatment market during this forecast period. Furthermore, growing preference to advanced drugs will also boost the consumption of aromatase inhibitors & SERMs, revenues from which will reach US$ 49 Mn by 2024-end.

Complete Report Details@ https://www.persistencemarketresearch.com/market-research/us-polycystic-ovarian-syndrome-treatment-market.asp

More than 47% of US PCOS market will be accounted by drug sales through hospital pharmacies. With hospitals as the largest distribution channel, nearly US$ 150 Mn worth of PCOS drugs will be sold through these pharmacies. Meanwhile, PCOS drug sales through e-commerce platforms are projected to showcase a value CAGR of 4.6%, higher than that of hospital pharmacies and other distribution channels such as fertility clinics, drug stores and over-the-top counters.

Related Reports:

Hepatitis C Treatment Market - https://www.persistencemarketresearch.com/market-research/hepatitis-c-treatment-market.asp

Compression Socks Market - https://www.persistencemarketresearch.com/market-research/compression-socks-market.asp

Contact Us:

Persistence Market Research
Address - 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. - +1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales - sales@persistencemarketresearch.com
Website - https://www.persistencemarketresearch.com

About Us:

Persistence Market Research is here to provide companies a one-stop solution with regards to bettering customer experience. It does engage in gathering appropriate feedback after getting through personalized customer interactions for adding value to customers' experience by acting as the "missing" link between "customer relationships" and "business outcomes'. The best possible returns are assured therein.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release The US Polycystic Ovarian Syndrome Treatment Market to prove to be the digitized mouthpiece at a CAGR of 3.9% here

News-ID: 2640122 • Views:

More Releases from Persistence Market Research

High Speed Steel (HSS) Metal Cutting Tools Market Innovations, Precision Engineering, and Emerging Trends Driving Industrial Machining
High Speed Steel (HSS) Metal Cutting Tools Market Innovations, Precision Enginee …
The High Speed Steel (HSS) metal cutting tools market is witnessing significant growth due to the increasing demand for efficient, precise, and durable machining solutions across diverse industries. HSS tools, renowned for their exceptional hardness, heat resistance, and versatility, are widely used in metal cutting applications including drilling, milling, turning, and threading. The global high speed steel (HSS) metal cutting tools market size is likely to be valued at US$
Medical Automation Market Expands as AI, Robotics, and IoT Drive Smarter Healthcare Systems
Medical Automation Market Expands as AI, Robotics, and IoT Drive Smarter Healthc …
The global medical automation market is poised for significant growth over the next decade, with projections indicating an expansion from US$48.7 billion in 2023 to US$84 billion by 2030, representing a robust compound annual growth rate (CAGR) of 8.1%. This growth trajectory reflects the increasing adoption of advanced automation technologies across healthcare facilities worldwide, driven by the rising demand for operational efficiency, precision in diagnostics, and enhanced patient care. Get a
Industrial X-ray Inspection Systems Market Advanced Imaging, Automation, and Emerging Trends Transforming Quality Control
Industrial X-ray Inspection Systems Market Advanced Imaging, Automation, and Eme …
The industrial X-ray inspection systems market is experiencing significant growth, driven by the increasing need for non-destructive testing, quality assurance, and process optimization across diverse industries. Industrial X-ray inspection systems are critical tools for detecting internal defects, structural inconsistencies, and product anomalies without damaging the components being tested. The global Industrial X-ray Inspection Systems Market size is likely to be valued at US$ 1.9 Bn by 2025, and estimated to
U.S. Intrathecal Drugs Market Forecasted to Expand from US$1.7 Billion to US$2.2 Billion by 2032
U.S. Intrathecal Drugs Market Forecasted to Expand from US$1.7 Billion to US$2.2 …
The U.S. intrathecal drugs market is poised for steady growth, with its value projected to rise from US$1.7 billion in 2025 to approximately US$2.2 billion by 2032. This reflects a compound annual growth rate (CAGR) of 3.8% during the forecast period of 2025-2032, underlining the expanding role of intrathecal therapies in pain management and spasticity treatment across the nation. Historical trends from 2019 to 2024 indicate consistent market expansion, fueled

All 5 Releases


More Releases for PCOS

Polycystic Syndrome (PCOS) Market Expected to Reach USD 7.9 Billion by 2034
Polycystic Syndrome (PCOS) is a complex hormonal disorder affecting women of reproductive age, characterized by irregular menstrual cycles, excessive androgen levels, and polycystic ovaries. Beyond its reproductive implications, PCOS is closely linked to metabolic issues such as insulin resistance, obesity, and increased risk of type 2 diabetes and cardiovascular diseases. Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/70728 Over the past decade, growing awareness, improved diagnostic capabilities, and greater emphasis
Empowering Women's Health: A New Era Dawns in the PCOS Therapeutics Market
Polycystic Ovarian Syndrome (PCOS) affects an estimated 8-13% of women of reproductive age worldwide, presenting a multifaceted challenge that spans hormonal imbalance, metabolic disruption, and reproductive health. Today, the PCOS therapeutics market stands at the forefront of medical innovation, as pharmaceutical companies, biotech startups, and academic researchers converge to address the unmet needs of millions of women. This industry outlines the latest trends, breakthrough therapies, and market dynamics shaping this
Global Efforts to Address Polycystic Ovarian Syndrome (PCOS) Gain Momentum
The Polycystic Ovarian Syndrome (PCOS) Treatment Market is expected to grow from an estimated USD 3514.5 million in 2024 to USD 5546.3 million in 2033, at a CAGR of 5.20%. Global initiatives to raise awareness and address Polycystic Ovarian Syndrome (PCOS) are making significant strides in improving women's health. The World Health Organization (WHO) highlights PCOS as a critical health disorder due to its impact on reproductive health, metabolic well-being,
Laser Hair Removal for PCOS: A Chicago Guide
Polycystic Ory Syndrome (PCOS) is a hormonal disorder that affects around 10% of women of reproductive age worldwide. PCOS leads to a range of symptoms like irregular menstrual cycles, insulin resistance, and more. The most challenging symptoms for many women with PCOS are excessive hair growth on their face, chest, and back. It's a condition known as hirsutism. Thanks to developments in laser hair removal Chicago https://vplaserhairremoval.com/laser-hair-removal-chicago-prices/ offers, individuals with
Discover Optimal PCOS Fertility Health Today with Dr. Angela Potter
Learn the secrets to optimal PCOS fertility health and improve the chances of pregnancy PORTLAND, OR - Polycystic ovarian syndrome (PCOS) is a condition often attributed to infertility, affecting more than five million women [https://www.endocrine.org/patient-engagement/endocrine-library/pcos] in the United States alone. Unfortunately, many women with PCOS are immediately pointed in the direction of in vitro fertilization (IVF) - a notoriously expensive procedure that does not guarantee a successful embryo transfer or pregnancy.
06-20-2024 | Health & Medicine
Fact.MR
PCOS Treatment Market Projected to Reach $6.84 Billion by 2034
According to a recent analysis by Fact.MR, the global (PCOS) treatments market is expected to experience significant growth in the coming years. This expansion is driven by several key factors: a rising incidence of PCOS, advancements in treatment methodologies, and a growing focus on women's health and wellness. Get Free Sample Research Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=10043 PCOS is one of the most prevalent endocrine disorders among women of reproductive age globally. It manifests through symptoms